Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-01-29 @ 6:48 AM
Study NCT ID:
NCT06972602
Status:
RECRUITING
Last Update Posted:
2025-05-15
First Post:
2025-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
Sponsor:
Eye & ENT Hospital of Fudan University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FD-EENT-2018044-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None